About
Dr. Wayne Holman is CEO and founder of Ridgeback Capital, a licensed physician trained at NYU School of Medicine with an economics degree from Yale. He co-founded Ridgeback Biotherapeutics, co-chairs the Ridgeback-Merck Molnupiravir Joint Steering Committee, and serves on the boards of NYU Langone and the University of Miami.